Crossmark

Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity

Crossref DOI link: https://doi.org/10.1039/D0TB00327A

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Zhang, Boya

Wan, Shiyu

Peng, Xinyu

Zhao, Mingying

Li, Sai

Pu, Yuji https://orcid.org/0000-0002-4465-0262
He, Bin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (51773130)

National Natural Science Foundation of China (51873121)

National Natural Science Foundation of China (51903172)

Fundamental Research Funds for the Central Universities (YJ201764)
License Information

Accepted Manuscript valid from 2021-03-25
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Yuji Pu (ORCID)

: Bin He (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 6 February 2020; Accepted 25 March 2020; Accepted Manuscript published 25 March 2020; Advance Article published 1 April 2020; Version of Record published 6 May 2020